{"id":"pooled-human-plasma","safety":{"commonSideEffects":[{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Allergic reactions"},{"rate":"null","effect":"Pain at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Pooled human plasma is a mixture of blood plasma from multiple donors, which is then used to treat patients with deficiencies in clotting factors or other proteins. This treatment can help to restore normal blood clotting and prevent bleeding complications.","oneSentence":"Pooled human plasma is used as a treatment for various conditions by providing a source of essential proteins and clotting factors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:51.036Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemophilia A"},{"name":"Hemophilia B"},{"name":"Congenital clotting factor deficiencies"}]},"trialDetails":[{"nctId":"NCT04502030","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia (\"PRO-SID\" Study)","status":"COMPLETED","sponsor":"Octapharma","startDate":"2020-10-05","conditions":"Chronic Lymphocytic Leukemia, Hypogammaglobulinemia","enrollment":247},{"nctId":"NCT06361537","phase":"PHASE3","title":"Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks","status":"RECRUITING","sponsor":"Octapharma","startDate":"2024-04-30","conditions":"Acute Hereditary Angio Edema","enrollment":124},{"nctId":"NCT07068126","phase":"NA","title":"Management of Children With Persistent ITP, A Novel Approach","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Persistent Immune Thrombocytopenia","enrollment":20},{"nctId":"NCT06934278","phase":"PHASE3","title":"Pooled Human Plasma vs Crystalloid in The Management of Children Undergoing Instrumented Spinal Fusion for Scoliosis","status":"RECRUITING","sponsor":"Turku University Hospital","startDate":"2025-05-02","conditions":"Adolescent Idiopathic Scoliosis (AIS), Neuromuscular Scoliosis","enrollment":194},{"nctId":"NCT05895136","phase":"PHASE2","title":"A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).","status":"RECRUITING","sponsor":"European Foundation for Study of Chronic Liver Failure","startDate":"2024-07-01","conditions":"Liver Cirrhosis, Decompensated Cirrhosis of Liver, Acute on Chronic Liver Failure (ACLF)","enrollment":90},{"nctId":"NCT05068830","phase":"PHASE2","title":"Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2021-09-17","conditions":"Alzheimer Disease","enrollment":60},{"nctId":"NCT04664738","phase":"PHASE1","title":"PEP on a Skin Graft Donor Site Wound","status":"UNKNOWN","sponsor":"Rion Inc.","startDate":"2021-03-16","conditions":"Skin Graft","enrollment":8},{"nctId":"NCT01376778","phase":"PHASE3","title":"A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2012-04","conditions":"Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection","enrollment":399},{"nctId":"NCT05575739","phase":"","title":"Evaluation of the Relationship Between Oxidative Stress and Human Reproduction","status":"UNKNOWN","sponsor":"Calla IVF Center","startDate":"2021-02-14","conditions":"IVF, Pregnancy, Oxidative Stress","enrollment":80},{"nctId":"NCT03784794","phase":"NA","title":"Patient Blood Management for Massive Obstetric Hemorrhage","status":"COMPLETED","sponsor":"Angel Augusto Perez Calatayud","startDate":"2018-11-01","conditions":"Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired","enrollment":100},{"nctId":"NCT03342638","phase":"PHASE3","title":"Maximizing Outcome of Multiple Sclerosis Transplantation","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2017-11-08","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":66},{"nctId":"NCT03715348","phase":"PHASE2","title":"Trial of PCC Versus FFP in Patients Undergoing Heart Surgery","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2019-03-01","conditions":"Bleeding, Surgery, Transfusion","enrollment":50},{"nctId":"NCT03749096","phase":"PHASE3","title":"Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2018-12-07","conditions":"Stiff-Person Syndrome","enrollment":""},{"nctId":"NCT02037555","phase":"PHASE2","title":"Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2014-06-26","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":425},{"nctId":"NCT01112735","phase":"PHASE2","title":"Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2010-05","conditions":"Seroma, Hematoma","enrollment":40},{"nctId":"NCT02449746","phase":"NA","title":"Study of Immunotherapy in Autoantibody Positive Psychosis","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2015-08","conditions":"Schizophrenia, Psychosis, Auto Immune Disorders","enrollment":10},{"nctId":"NCT02427217","phase":"","title":"An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2015-05-07","conditions":"Congenital Fibrinogen Deficiency","enrollment":22},{"nctId":"NCT00411801","phase":"PHASE3","title":"Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)","status":"TERMINATED","sponsor":"Octapharma","startDate":"2007-05","conditions":"Thrombotic Thrombocytopenic Purpura (TTP)","enrollment":8},{"nctId":"NCT01698567","phase":"PHASE1","title":"Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2012-07","conditions":"Congenital Heart Disease","enrollment":6},{"nctId":"NCT01684410","phase":"PHASE2","title":"Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2012-08","conditions":"Cystic Fibrosis","enrollment":30},{"nctId":"NCT02230163","phase":"PHASE1, PHASE2","title":"Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de la Guadeloupe","startDate":"2014-09","conditions":"Chikungunya Virus Infection","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Pooled human plasma","genericName":"Pooled human plasma","companyName":"Turku University Hospital","companyId":"turku-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pooled human plasma is used as a treatment for various conditions by providing a source of essential proteins and clotting factors. Used for Hemophilia A, Hemophilia B, Congenital clotting factor deficiencies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}